Trudhesa: A New Delivery System for DHE
In this episode, Dr. Schim joins us to discuss Trudhesa, a newly approved abortive migraine treatment option. He explains the technology behind this new administration method for Dihydroergotamine nasal spray as well as efficacy and safety data. *The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
Embed this episode
No transcript yet.